Bioventix (LON:BVXP) Insider Bruce Hiscock Purchases 150 Shares of Stock

Bioventix PLC (LON:BVXP) insider Bruce Hiscock acquired 150 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The shares were purchased at an average cost of GBX 2,071 per share, for a total transaction of £3,106.50.

Bruce Hiscock also recently made the following trade(s):

• On Monday, October 27th, Bruce Hiscock bought 119 shares of Bioventix stock. The shares were acquired at an average price of GBX 2,009 per share, for a total transaction of £2,390.71.

Bioventix Stock Down 1.2%

LON BVXP opened at GBX 2,025 on Thursday. Bioventix PLC has a twelve month low of GBX 1,750 and a twelve month high of GBX 3,850. The stock has a market cap of £105.81 million, a P/E ratio of 14.13 and a beta of 0.35. The company’s 50-day simple moving average is GBX 2,265.05 and its 200 day simple moving average is GBX 2,517.68.

Bioventix (LON:BVXP) last announced its quarterly earnings results on Monday, October 27th. The biotechnology company reported GBX 145.27 EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. Research analysts anticipate that Bioventix PLC will post 166.3066955 earnings per share for the current year.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.